abrdn, a global investment company, led a $20m funding round Eagle Genomics, a developer of a knowledge discovery platform, with participation from ETF Partners and Granpool Innovative Investments. "We are the pre-eminent platform business using next-generation graph technology and network science to drive the Bioeconomy. We are seeking to support our enterprise customers as they strive to achieve more sustainable and impact-orientated innovation outcomes. The current scale-up funding will enable us to accelerate the Bioeconomy through the digital reinvention of science," Anthony Finbow, Eagle Genomics CEO.